These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26859127)

  • 1. Prognostic significance of EZH2 expression in patients with oesophageal cancer: a meta-analysis.
    Wang Y; Gao F; Zhao M; Li B; Xing D; Wang J; Yang Y
    J Cell Mol Med; 2016 May; 20(5):836-41. PubMed ID: 26859127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of EZH2 expression in patients with digestive cancers: a meta-analysis.
    Wang W; Wang F; Zong G; Liu R; Zhang Y; Luan Y; Xu L; Xuan J
    Int J Clin Exp Med; 2015; 8(9):16043-9. PubMed ID: 26629110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of EZH2 in overall survival of colorectal cancer: a meta-analysis.
    Vilorio-Marqués L; Martín V; Diez-Tascón C; González-Sevilla MF; Fernández-Villa T; Honrado E; Davila-Batista V; Molina AJ
    Sci Rep; 2017 Oct; 7(1):13806. PubMed ID: 29061982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis.
    Wang X; Zhao H; Lv L; Bao L; Wang X; Han S
    Sci Rep; 2016 Jan; 6():19239. PubMed ID: 26754405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of Sox2 expression in digestive tract cancers: A meta-analysis.
    Du XM; Wang LH; Chen XW; Li YX; Li YC; Cao YW
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):305-312. PubMed ID: 27376796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of polycomb group protein expression in advanced gastric cancer.
    Lee H; Yoon SO; Jeong WY; Kim HK; Kim A; Kim BH
    Hum Pathol; 2012 Oct; 43(10):1704-10. PubMed ID: 22520951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant overexpression of EZH2 and H3K27me3 serves as poor prognostic biomarker for esophageal squamous cell carcinoma patients.
    Liu F; Gu L; Cao Y; Fan X; Zhang F; Sang M
    Biomarkers; 2016; 21(1):80-90. PubMed ID: 26631178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-expression of Bmi1 and EZH2 as an independent poor prognostic factor in esophageal squamous cell carcinoma.
    Ha SY; Kim SH
    Pathol Res Pract; 2012 Aug; 208(8):462-9. PubMed ID: 22766604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2 overexpression is associated with poor prognosis in patients with glioma.
    Zhang Y; Yu X; Chen L; Zhang Z; Feng S
    Oncotarget; 2017 Jan; 8(1):565-573. PubMed ID: 27880940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of overexpression of EZH2 and H3k27me3 proteins in gastric cancer.
    He LJ; Cai MY; Xu GL; Li JJ; Weng ZJ; Xu DZ; Luo GY; Zhu SL; Xie D
    Asian Pac J Cancer Prev; 2012; 13(7):3173-8. PubMed ID: 22994729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    He LR; Liu MZ; Li BK; Jia WH; Zhang Y; Liao YJ; Chen YC; Zhang LJ; Guan XY; Zeng YX; Kung HF; Xie D
    Int J Cancer; 2010 Jul; 127(1):138-47. PubMed ID: 19904743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis.
    Peng L; Zhan P; Zhou Y; Fang W; Zhao P; Zheng Y; Xu N
    Mol Biol Rep; 2012 Oct; 39(10):9473-84. PubMed ID: 22729879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of EZH2 protein expression in gastric carcinogenesis among Asians: a meta-analysis.
    Guo L; Yang TF; Liang SC; Guo JX; Wang Q
    Tumour Biol; 2014 Jul; 35(7):6649-56. PubMed ID: 24705718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysis.
    Chen S; Huang L; Sun K; Wu D; Li M; Li M; Zhong B; Chen M; Zhang S
    PLoS One; 2015; 10(5):e0125480. PubMed ID: 25974088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis.
    Jiang Q; Sun Y; Liu X
    Biomarkers; 2019 Sep; 24(6):510-516. PubMed ID: 31244335
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer.
    Matsukawa Y; Semba S; Kato H; Ito A; Yanagihara K; Yokozaki H
    Cancer Sci; 2006 Jun; 97(6):484-91. PubMed ID: 16734726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the enhancer of zeste homolog 2 in biopsy specimen predicts chemoresistance and survival in advanced non-small cell lung cancer receiving first-line platinum-based chemotherapy.
    Xu C; Hao K; Hu H; Sheng Z; Yan J; Wang Q; Yu L
    Lung Cancer; 2014 Nov; 86(2):268-73. PubMed ID: 25262426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of enhancer of zeste homologue 2, correlated with HIF-1α, refines relapse risk and predicts poor outcome for breast cancer.
    Dong M; Fan XJ; Chen ZH; Wang TT; Li X; Chen J; Lin Q; Wen JY; Ma XK; Wei L; Ruan DY; Lin ZX; Liu Q; Wu XY; Wan XB
    Oncol Rep; 2014 Sep; 32(3):1101-7. PubMed ID: 25017254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancer of Zeste Homolog 2 in Colorectal Cancer Development and Progression.
    Bremer SCB; Conradi LC; Mechie NC; Amanzada A; Mavropoulou E; Kitz J; Ghadimi M; Ellenrieder V; Ströbel P; Hessmann E; Gaedcke J; Bohnenberger H
    Digestion; 2021; 102(2):227-235. PubMed ID: 31694013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.